Spots Global Cancer Trial Database for sirt
Every month we try and update this database with for sirt cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| REgistry of Selective Internal Radiation Therapy in TaiwaN (RESIN) | NCT03292991 | Hepatocellular ... | 20 Years - | Taipei Veterans General Hospital, Taiwan | ||
| Yttrium-90 Carbon Microspheres in Patients With Unresectable Hepatocellular Carcinoma | NCT05957640 | Unresectable He... | Yttrium-90 carb... | 18 Years - 75 Years | Zhongda Hospital | |
| Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma. | NCT05451862 | Hepatocellular ... | Holmium-166 tre... Holmium-166 wor... | 18 Years - | Terumo Europe N.V. | |
| Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer | NCT06079242 | Colorectal Neop... | Resin microsphe... | 18 Years - | GrandPharma (China) Co., Ltd. | |
| SIRT for Potentially Resectable HCC | NCT05994859 | Hepatocellular ... | SIRT | 18 Years - 75 Years | Second Affiliated Hospital of Guangzhou Medical University | |
| Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study) | NCT04833517 | Prostate Cancer... Castration Resi... Advanced Prosta... | 18 Years - | Universität des Saarlandes | ||
| Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC). | NCT01798160 | Hepatocellular ... | DEB TACE SIRT | 18 Years - | Johannes Gutenberg University Mainz | |
| Yttrium-90 Carbon Microspheres in Patients With Unresectable Hepatocellular Carcinoma | NCT05957640 | Unresectable He... | Yttrium-90 carb... | 18 Years - 75 Years | Zhongda Hospital | |
| Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC). | NCT01798147 | Intrahepatic Ch... | DEB TACE SIRT | 18 Years - | Johannes Gutenberg University Mainz | |
| Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis | NCT02936388 | Uveal Melanoma | SIRT DSM-TACE | 18 Years - 99 Years | Charite University, Berlin, Germany | |
| Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRT | NCT00994370 | Liver Cancer | 18 Years - 85 Years | Rutgers, The State University of New Jersey | ||
| CIRSE Registry for SIR-Spheres Therapy | NCT02305459 | Liver Carcinoma | Yttrium-90 load... QLQ-C30 with HC... | 18 Years - | Cardiovascular and Interventional Radiological Society of Europe | |
| Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver | NCT01686880 | Hepatocellular ... Liver Cirrhosis | Sirsphere trans... | 18 Years - | Jules Bordet Institute | |
| Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients | NCT06142344 | Liver Metastase... Breast Cancer | Quiremspheres™ | 18 Years - | The Netherlands Cancer Institute | |
| Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases | NCT02195011 | Colorectal Neop... | SIR-Spheres Regorafenib | 18 Years - | SCRI Development Innovations, LLC | |
| Durvalumab and Tremelimumab in Combination With Either Y-90 SIRT or DEB-TACE for Intermediate Stage HCC | NCT04522544 | Hepatocellular ... HCC | Tremelimumab Durvalumab Y-90 SIRT DEB-TACE | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Durvalumab and Tremelimumab in Combination With Either Y-90 SIRT or DEB-TACE for Intermediate Stage HCC | NCT04522544 | Hepatocellular ... HCC | Tremelimumab Durvalumab Y-90 SIRT DEB-TACE | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| SIRT With Tremelimumab and Durvalumab for Resectable HCC | NCT05701488 | Resectable Hepa... Hepatocellular ... Hepatocellular ... | Durvalumab Tremelimumab SIRT | 18 Years - | Dana-Farber Cancer Institute | |
| Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer | NCT00604409 | Metastatic Live... | SIRT capecitabine | 18 Years - | Fox Chase Cancer Center | |
| Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients | NCT06142344 | Liver Metastase... Breast Cancer | Quiremspheres™ | 18 Years - | The Netherlands Cancer Institute | |
| Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRT | NCT00994370 | Liver Cancer | 18 Years - 85 Years | Rutgers, The State University of New Jersey | ||
| Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry) | NCT05967143 | Unresectable He... Liver Metastase... | SIRT | 18 Years - | Sirtex Medical | |
| Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer | NCT06079242 | Colorectal Neop... | Resin microsphe... | 18 Years - | GrandPharma (China) Co., Ltd. | |
| Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver | NCT01686880 | Hepatocellular ... Liver Cirrhosis | Sirsphere trans... | 18 Years - | Jules Bordet Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
